PureTech Health PLC | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,435.20
40,489.30
213,401.20
228,516.20
140,213.60
198,710.70
Total Accounts Receivable
1,612.10
1,122.30
479.00
101.20
1,328.40
1,042.70
Other Current Assets
280.80
1,177.50
2,011.00
4,582.20
4,907.00
4,224.20
Total Current Assets
7,328.00
42,789.20
215,891.20
233,199.50
146,449.10
203,977.70
Net Property, Plant & Equipment
732.40
786.90
3,066.00
5,603.50
5,072.60
6,535
Total Investments and Advances
151.50
50.00
86.20
84.20
97,099.20
133,287.50
Intangible Assets
1,909.10
1,923.40
2,626.40
2,851.90
2,446.10
2,418.30
Other Assets
1.80
3.20
24.40
35.60
54.00
290.50
Total Assets
10,122.90
45,552.70
221,694.10
241,774.80
251,226.00
346,861.70
ST Debt & Current Portion LT Debt
8,434.70
11,827.50
47,803.10
84,077.20
94,256.90
Accounts Payable
546.40
1,035.10
1,623.60
1,680.90
2,509.00
Other Current Liabilities
4,760.80
47,213.10
59,484.40
79,401.90
105,682.50
Total Current Liabilities
13,741.90
60,075.70
108,911.10
165,160.00
202,448.30
Deferred Taxes
-
-
-
-
105.00
Other Liabilities
1,227.50
428.40
1,477.70
1,827.40
1,468.90
Total Liabilities
14,969.40
60,504.10
110,388.80
166,987.40
203,917.20
Common Equity (Total)
533.70
14,111.90
153,418.10
143,783.40
158,419.50
Total Shareholders' Equity
533.70
14,111.90
153,418.10
143,783.40
158,419.50
Total Equity
4,846.50
14,951.40
111,305.40
74,787.40
47,308.80
Liabilities & Shareholders' Equity
10,122.90
45,552.70
221,694.10
241,774.80
251,226.00
Accumulated Minority Interest
4,312.80
29,063.30
42,112.80
68,996.10
111,110.70

About PureTech Health

View Profile
Address
6 Tide Street
Boston Massachusetts 02210
United States
Employees -
Website http://puretechhealth.com/
Updated 07/08/2019
PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Growth Stage Affiliates, Project Phase Programmes, Independent Affiliate Programmes, and Parent Company and Other. The Growth Stage Affiliates segment focuses on the development on products to solve major healthcare problems in varied markets.